{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01343043",
      "OrgStudyIdInfo": {
        "OrgStudyId": "208466"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "ADP 04511",
            "SecondaryIdType": "Other Identifier",
            "SecondaryIdDomain": "Adaptimmune Therapeutics"
          },
          {
            "SecondaryId": "2015-005594-21",
            "SecondaryIdType": "EudraCT Number"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "GlaxoSmithKline",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma",
      "OfficialTitle": "A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma",
      "Acronym": "NY-ESO-1"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2021",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 27, 2012",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 18, 2019",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "June 18, 2019",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "April 26, 2011",
      "StudyFirstSubmitQCDate": "April 26, 2011",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 27, 2011",
        "StudyFirstPostDateType": "Estimate"
      },
      "ResultsFirstSubmitDate": "June 18, 2020",
      "ResultsFirstSubmitQCDate": "June 18, 2020",
      "ResultsFirstPostDateStruct": {
        "ResultsFirstPostDate": "July 9, 2020",
        "ResultsFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "June 9, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 30, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "GlaxoSmithKline",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this early (pilot) clinical trial is to test the effects (both good and bad) of chemotherapy and adoptive immunotherapy with T cells engineered to recognize NY-ESO-1 peptide in patients with unresectable, metastatic or recurrent synovial sarcoma.",
      "DetailedDescription": "Design\n\nPatients will undergo apheresis at the enrolling institution. PBMC will be shipped to a central manufacturer for gene transduction, activation and expansion, then cryopreserved and shipped back to the enrolling institution.\n\nThe trial seeks to enroll up to 65 patients, that is, up to 20 patients in Cohort 1 and up to 15 patients in Cohorts 2-4. Depending on the cohort patients are enrolled in, patients will undergo lymphodepletion with cyclophosphamide with or without fludarabine.\n\nCohort 1: Complete\nCohort 2: Up to 15 patients may be enrolled to achieve at least 10 evaluable patients treated with NY-ESO-1ᶜ²⁵⁹T. Patients will undergo lymphodepletion with cyclophosphamide plus fludarabine on Days -3 and -2, and without fludarabine on Days -5 and -4.\nCohort 3: Up to 15 patients may be enrolled to achieve at least 10 evaluable patients treated with NY-ESO-1ᶜ²⁵⁹T. Patients will undergo lymphodepletion with cyclophosphamide only on Days -3 and -2. (Cohort Complete)\nCohort 4: Up to 15 patients may be enrolled to achieve at least 5 evaluable patients treated with NY-ESO-1ᶜ²⁵⁹T. Patients will undergo lymphodepletion with cyclophosphamide plus fludarabine on Days -7 to -5.\n\nOn Day 0, patients ≥40 kg will receive the minimum cell dose of at least 1x10⁹ transduced NY-ESO-1ᶜ²⁵⁹T cells with a maximum of 6x10⁹ transduced cells. The target dose for this protocol is 5x10⁹ transduced NY-ESO-1ᶜ²⁵⁹T cells. Patients <40 kg will be dosed per body weight with a minimum 0.025x10⁹ transduced cells/kg, with a target dose of 0.125 x10⁹ transduced cells/kg.\n\nPatients will be monitored for toxicity, antitumor effects and immune endpoints.\nPatients who have a confirmed response, or have stable disease for >3 months then progress may receive a 2nd T cell infusion, provided eligibility criteria are met. The 2nd treatment cell infusion will be administered in the same manner as the first. Patients who meet the eligibility criteria may receive a 2nd infusion of NY-ESO-1ᶜ²⁵⁹T no sooner than 60 days and no later than 2 years following completion of the first treatment."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Neoplasms"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "T Cell Receptor",
          "Sarcoma",
          "Cell Therapy",
          "T Cell Therapy",
          "Previously treated",
          "NY-ESO-1",
          "Metastatic",
          "Immuno-oncology"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment"
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "50",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Cohort 1 treated with NY-ESO-1 T Cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "High NY-ESO-1 expression and the use of cyclophosphamide plus fludarabine as the lymphodepleting chemotherapy.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: NY-ESO-1(c259)T Cells",
                "Drug: Fludarabine",
                "Drug: Cyclophosphamide"
              ]
            }
          },
          {
            "ArmGroupLabel": "Cohort 2 treated with NY-ESO-1 T Cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Low NY-ESO-1 expression and the use of cyclophosphamide plus fludarabine as the lymphodepleting chemotherapy.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: NY-ESO-1(c259)T Cells",
                "Drug: Fludarabine",
                "Drug: Cyclophosphamide"
              ]
            }
          },
          {
            "ArmGroupLabel": "Cohort 3 treated with NY-ESO-1 T Cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "High NYESO-1 expression and the use of cyclophosphamide only for lymphodepletion rather than fludarabine as the lymphodepleting chemotherapy.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: NY-ESO-1(c259)T Cells",
                "Drug: Cyclophosphamide"
              ]
            }
          },
          {
            "ArmGroupLabel": "Cohort 4 treated with NY-ESO-1 T Cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "High NY-ESO-1 expression and the use of reduced dose cyclophosphamide plus fludarabine regimen as the lymphodepleting chemotherapy.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: NY-ESO-1(c259)T Cells",
                "Drug: Fludarabine",
                "Drug: Cyclophosphamide"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "NY-ESO-1(c259)T Cells",
            "InterventionDescription": "Lymphodepleting chemotherapy followed by infusion with NY-ESO-1(c259) transduced autologous T cells. Subjects will receive one infusion of NY-ESO-1 genetically engineered T cells on Day 0.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cohort 1 treated with NY-ESO-1 T Cells",
                "Cohort 2 treated with NY-ESO-1 T Cells",
                "Cohort 3 treated with NY-ESO-1 T Cells",
                "Cohort 4 treated with NY-ESO-1 T Cells"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Fludarabine",
            "InterventionDescription": "Fludarabine will be used as lymphodepleting chemotherapy.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cohort 1 treated with NY-ESO-1 T Cells",
                "Cohort 2 treated with NY-ESO-1 T Cells",
                "Cohort 4 treated with NY-ESO-1 T Cells"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Cyclophosphamide",
            "InterventionDescription": "Cyclophosphamide will be used as lymphodepleting chemotherapy.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cohort 1 treated with NY-ESO-1 T Cells",
                "Cohort 2 treated with NY-ESO-1 T Cells",
                "Cohort 3 treated with NY-ESO-1 T Cells",
                "Cohort 4 treated with NY-ESO-1 T Cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Objective Response Rate (ORR)",
            "PrimaryOutcomeDescription": "ORR was calculated as the percentage of participants with a confirmed complete response (CR) or partial response (PR) relative to the total number of participants in the analysis population per response evaluation criteria in solid tumors (RECIST) version (v)1.1 as determined by the local investigators.",
            "PrimaryOutcomeTimeFrame": "Up to 4.5 years"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Duration of Overall Response",
            "SecondaryOutcomeDescription": "Duration of overall response (DOR) is defined as the time from first documented evidence of confirmed CR or confirmed PR until first documented date of disease progression or death due to any cause or surgical resection or start of prohibited medications. Duration of overall response was evaluated per RECIST v1.1. Median and full range of DOR are presented.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Progression Free Survival",
            "SecondaryOutcomeDescription": "Progression free survival is defined as the interval between the date of first T cell infusion and the earliest documented evidence of disease progression or death due to any cause or surgical resection or start of prohibited medications. Progression free survival was evaluated per RECIST v1.1. Median and inter-quartile range (first quartile and third quartile) of progression free survival are presented.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Best Overall Response",
            "SecondaryOutcomeDescription": "Best overall response is the best response recorded from the start of treatment (first T cell infusion) until disease progression/recurrence. Response categories from best to worst are confirmed CR, confirmed PR, stable disease (SD) and confirmed progressive disease (PD). Best overall response is a stable disease, if CR or PR are unconfirmed. Data for number of participants with CR, PR, SD and PD are presented.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Overall Survival",
            "SecondaryOutcomeDescription": "Overall survival is defined as the interval between the date of the first T-cell infusion and date of death from any cause. Median and inter-quartile range (first quartile and third quartile) of overall survival are presented.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Number of Participants With Non-serious Adverse Events (Non-SAEs) and Serious Adverse Events (SAEs)",
            "SecondaryOutcomeDescription": "An adverse event (AE) is any untoward medical occurrence in a clinical study participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. SAE is defined as any untoward medical occurrence that; results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect, other situations judged by physician, is associated with liver injury and impaired liver function. Number of participants who had non-SAEs and SAEs are presented.",
            "SecondaryOutcomeTimeFrame": "Up to 5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Number of Participants With Worst Post-Baseline Grade Results for Hematology Parameters",
            "SecondaryOutcomeDescription": "Blood samples were collected for the analysis of hematology parameters. No data collected separately for this outcome measure as any abnormal value would be recorded as an adverse event.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Number of Participants With Worst Post-Baseline Grade Results for Clinical Chemistry Parameters",
            "SecondaryOutcomeDescription": "Blood samples were collected for the analysis of clinical chemistry parameters. No data collected separately for this outcome measure as any abnormal value would be recorded as an adverse event.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Number of Participants With at Least One Confirmed Positive Post-Baseline Anti-infused (NY-ESO-1 Genetically Engineered T) Cell Antibody Result",
            "SecondaryOutcomeDescription": "Serum samples were collected for the determination of anti-infused (NY-ESO-1 genetically engineered T) cell antibodies (ATA) using a validated electrochemiluminescent (ECL) immunoassay. The assay involved screening, confirmation and titration steps. If serum samples tested positive in the screening assay, they were considered 'potentially positive' and were further analyzed for the specificity using the confirmation assay. A participant was considered to have a confirmed positive ATA result if they have a positive screening assay result and a positive confirmation assay result.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "SecondaryOutcomeMeasure": "Concentration of Cytokines in Cytokine Release Syndrome (CRS) by CRS Status: Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
            "SecondaryOutcomeDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "SecondaryOutcomeTimeFrame": "Up to Week 4"
          },
          {
            "SecondaryOutcomeMeasure": "Concentration of Cytokines in CRS by CRS Status: Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
            "SecondaryOutcomeDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "SecondaryOutcomeTimeFrame": "Up to Week 4"
          },
          {
            "SecondaryOutcomeMeasure": "Concentration of Cytokines in CRS by CRS Status: Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
            "SecondaryOutcomeDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "SecondaryOutcomeTimeFrame": "Up to Week 4"
          },
          {
            "SecondaryOutcomeMeasure": "Concentration of Cytokines in CRS by CRS Status: Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
            "SecondaryOutcomeDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "SecondaryOutcomeTimeFrame": "Up to Week 4"
          },
          {
            "SecondaryOutcomeMeasure": "Time to Maximum Persistence of NY-ESO-1 Genetically Engineered T Cells",
            "SecondaryOutcomeDescription": "Time to maximum persistence is defined as date of maximum persistence for infusion visit minus date of first T cell infusion visit plus 1. Median and full range of time to maximum persistence are presented.",
            "SecondaryOutcomeTimeFrame": "Up to 4.5 years"
          }
        ]
      },
      "OtherOutcomeList": {
        "OtherOutcome": [
          {
            "OtherOutcomeMeasure": "Number of Participants With Dose-limiting Toxicities (DLTs)",
            "OtherOutcomeDescription": "DLT was planned to be evaluated. An event was to be considered a DLT if it occurred within the first 21 days of treatment, and met one of the protocol defined DLT criteria. The results for this outcome measure will never be posted.",
            "OtherOutcomeTimeFrame": "Up to Day 21 (from first dose)"
          },
          {
            "OtherOutcomeMeasure": "Number of Participants With Clinically Significant Abnormal Electrocardiogram, Echocardiogram and Multigated Acquisition Scan Findings",
            "OtherOutcomeDescription": "Abnormal electrocardiogram, echocardiogram and multigated acquisition scan findings were planned to be evaluated. Clinical significance was based on the medical and scientific judgement of the investigator or qualified designee. The results for this outcome measure will never be posted.",
            "OtherOutcomeTimeFrame": "Up to 4.5 years"
          },
          {
            "OtherOutcomeMeasure": "Percentage of Participants With Confirmed CR",
            "OtherOutcomeDescription": "Participants were planned to be evaluated for confirmed CR according to RECIST v1.1, after receiving a second dose of NY-ESO-1 genetically engineered T cell infusion. The results for this outcome measure will never be posted.",
            "OtherOutcomeTimeFrame": "Up to 4.5 years"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSynovial sarcoma that has been treated with standard chemotherapy containing ifosfamide and/or doxorubicin and remains: unresectable or metastatic or progressive/persistent or recurrent disease\nMeasurable disease\n\nPatients must have proven positive tumor sample for NY-ESO-1 as follows:\n\nCohort 1 -Positive expression is defined as 2+ and/or 3+ by immunohistochemistry in ≥ 50% of cells.\nCohort 2 -Positive expression is defined as ≥1+ by immunohistochemistry in ≥1% cells, but not to exceed 2+ and/or 3+ in ≥ 50% of cells.\nCohort 3 -Positive expression is defined as 2+ and/or 3+ by immunohistochemistry in ≥ 50% of cells.\nCohort 4 -Positive expression is defined as 2+ and/or 3+ by immunohistochemistry in ≥ 50% of cells.\nHLA-A*02:01, HLA-A*02:05, and/or HLA-A*02:06 by high resolution testing at a local or central laboratory\nWeigh more than 18 kg\nAll previous cytotoxic chemotherapy, monoclonal antibody therapy, or immune therapy must be washed out 3 weeks before apheresis and must be completed at least 3 weeks prior to pre-infusion lymphodepletive chemotherapy.\nSystemic corticosteroid or other immunosuppressive therapy should be washed out 2 weeks before apheresis and must be completed at least 2 weeks prior to pre-infusion lymphodepletive chemotherapy.\nBiologic or other approved molecular targeted small molecule inhibitors should be washed out 1 week or 5 half-lives (whichever is longer) before apheresis and must be completed at least 1 week or 5 half-lives (whichever is longer) prior to pre-infusion lymphodepletive chemotherapy.\nAny grade 3 or 4 hematologic toxicity of any previous therapy must have resolved to grade 2 or less prior to apheresis and any grade 3 or 4 toxicity must have resolved to grade 2 or less prior to pre-infusion lymphodepletive chemotherapy.\nECOG 0-1, or for children ≤10 years of age, Lansky > 60\nLife expectancy > 3 months\nLeft ventricular ejection fraction ≥ 40% or fractional shortening ≥ 28%\nT. bilirubin < 2 mg/dl (Patients with Gilbert Syndrome total bilirubin <3xULN and direct bilirubin ≤ 35%)\nAST, ALT ≤ 2.5 x upper limit of normal\nANC ≥ 1.0 x 10⁹/L\nPlatelets ≥ 75 x 10⁹/L\nAge-adjusted normal serum creatinine or a creatinine clearance ≥ 40 ml/min\nAbility to give informed consent for patients greater than 18 years of age. For patients less than 18 years of age the legal guardian must give informed consent.\nMale patients must be willing to practice birth control (including abstinence) during and for 4 months after treatment. Female patients must be willing to practice birth control (including abstinence) during treatment and for 4 months after gene modified cells are no longer detected in body.\n\nExclusion Criteria:\n\nActive HIV, HBV, HCV or HTLV 1/2 infection (due to increased risk of complications during lymphodepleting regimen and confounding effects on the immune system). Active hepatitis B or C infection is defined by seropositive for hepatitis B surface antigen (HbSAg) or hepatitis C antibody.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "4 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "GSK Clinical Trials",
            "OverallOfficialAffiliation": "GlaxoSmithKline",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "Duarte",
            "LocationState": "California",
            "LocationZip": "91010",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "Miami",
            "LocationState": "Florida",
            "LocationZip": "33136",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "Tampa",
            "LocationState": "Florida",
            "LocationZip": "33612",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "Bethesda",
            "LocationState": "Maryland",
            "LocationZip": "20892",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "Boston",
            "LocationState": "Massachusetts",
            "LocationZip": "02114",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "Saint Louis",
            "LocationState": "Missouri",
            "LocationZip": "63110",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "New York",
            "LocationState": "New York",
            "LocationZip": "10065",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "GSK Investigational Site",
            "LocationCity": "Houston",
            "LocationState": "Texas",
            "LocationZip": "77030",
            "LocationCountry": "United States"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "31651363",
            "ReferenceType": "derived",
            "ReferenceCitation": "Ramachandran I, Lowther DE, Dryer-Minnerly R, Wang R, Fayngerts S, Nunez D, Betts G, Bath N, Tipping AJ, Melchiori L, Navenot JM, Glod J, Mackall CL, D'Angelo SP, Araujo DM, Chow WA, Demetri GD, Druta M, Van Tine BA, Grupp SA, Abdul Razak AR, Wilky B, Iyengar M, Trivedi T, Winkle EV, Chagin K, Amado R, Binder GK, Basu S. Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma. J Immunother Cancer. 2019 Oct 24;7(1):276. doi: 10.1186/s40425-019-0762-2."
          },
          {
            "ReferencePMID": "29891538",
            "ReferenceType": "derived",
            "ReferenceCitation": "D'Angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, Grupp S, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite L, Amado R, Mackall CL. Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 (c259)T Cells in Synovial Sarcoma. Cancer Discov. 2018 Aug;8(8):944-957. doi: 10.1158/2159-8290.CD-17-1417. Epub 2018 Jun 11."
          }
        ]
      }
    }
  },
  "ResultsSection": {
    "ParticipantFlowModule": {
      "FlowPreAssignmentDetails": "A total of 50 participants were enrolled in this study. Out of 50 participants, 45 participants received NY-ESO-1 genetically engineered T cell infusion.",
      "FlowRecruitmentDetails": "This study was designed to determine whether New York esophageal squamous cell carcinoma 1 (NY-ESO-1) specific genetically engineered T cells recognized a human leukocyte antigens (HLA-A2) binding peptide from NY-ESO-1 induced antitumor responses in participants with synovial sarcoma.",
      "FlowGroupList": {
        "FlowGroup": [
          {
            "FlowGroupId": "FG000",
            "FlowGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
            "FlowGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
          },
          {
            "FlowGroupId": "FG001",
            "FlowGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
            "FlowGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
          },
          {
            "FlowGroupId": "FG002",
            "FlowGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
            "FlowGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
          },
          {
            "FlowGroupId": "FG003",
            "FlowGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
            "FlowGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
          }
        ]
      },
      "FlowPeriodList": {
        "FlowPeriod": [
          {
            "FlowPeriodTitle": "Overall Study",
            "FlowMilestoneList": {
              "FlowMilestone": [
                {
                  "FlowMilestoneType": "STARTED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "15"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "14"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "5"
                      },
                      {
                        "FlowAchievementGroupId": "FG003",
                        "FlowAchievementNumSubjects": "16"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "Received T-cell Infusion",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "12"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "13"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "5"
                      },
                      {
                        "FlowAchievementGroupId": "FG003",
                        "FlowAchievementNumSubjects": "15"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "12"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "13"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "5"
                      },
                      {
                        "FlowAchievementGroupId": "FG003",
                        "FlowAchievementNumSubjects": "15"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "NOT COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "3"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "1"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "0"
                      },
                      {
                        "FlowAchievementGroupId": "FG003",
                        "FlowAchievementNumSubjects": "1"
                      }
                    ]
                  }
                }
              ]
            },
            "FlowDropWithdrawList": {
              "FlowDropWithdraw": [
                {
                  "FlowDropWithdrawType": "Disease progression before treatment",
                  "FlowReasonList": {
                    "FlowReason": [
                      {
                        "FlowReasonGroupId": "FG000",
                        "FlowReasonNumSubjects": "1"
                      },
                      {
                        "FlowReasonGroupId": "FG001",
                        "FlowReasonNumSubjects": "0"
                      },
                      {
                        "FlowReasonGroupId": "FG002",
                        "FlowReasonNumSubjects": "0"
                      },
                      {
                        "FlowReasonGroupId": "FG003",
                        "FlowReasonNumSubjects": "0"
                      }
                    ]
                  }
                },
                {
                  "FlowDropWithdrawType": "Withdrawal by Subject",
                  "FlowReasonList": {
                    "FlowReason": [
                      {
                        "FlowReasonGroupId": "FG000",
                        "FlowReasonNumSubjects": "1"
                      },
                      {
                        "FlowReasonGroupId": "FG001",
                        "FlowReasonNumSubjects": "0"
                      },
                      {
                        "FlowReasonGroupId": "FG002",
                        "FlowReasonNumSubjects": "0"
                      },
                      {
                        "FlowReasonGroupId": "FG003",
                        "FlowReasonNumSubjects": "0"
                      }
                    ]
                  }
                },
                {
                  "FlowDropWithdrawType": "Death",
                  "FlowReasonList": {
                    "FlowReason": [
                      {
                        "FlowReasonGroupId": "FG000",
                        "FlowReasonNumSubjects": "1"
                      },
                      {
                        "FlowReasonGroupId": "FG001",
                        "FlowReasonNumSubjects": "1"
                      },
                      {
                        "FlowReasonGroupId": "FG002",
                        "FlowReasonNumSubjects": "0"
                      },
                      {
                        "FlowReasonGroupId": "FG003",
                        "FlowReasonNumSubjects": "1"
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "BaselineCharacteristicsModule": {
      "BaselineGroupList": {
        "BaselineGroup": [
          {
            "BaselineGroupId": "BG000",
            "BaselineGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
            "BaselineGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
          },
          {
            "BaselineGroupId": "BG001",
            "BaselineGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
            "BaselineGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
          },
          {
            "BaselineGroupId": "BG002",
            "BaselineGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
            "BaselineGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
          },
          {
            "BaselineGroupId": "BG003",
            "BaselineGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
            "BaselineGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
          },
          {
            "BaselineGroupId": "BG004",
            "BaselineGroupTitle": "Total",
            "BaselineGroupDescription": "Total of all reporting groups"
          }
        ]
      },
      "BaselineDenomList": {
        "BaselineDenom": [
          {
            "BaselineDenomUnits": "Participants",
            "BaselineDenomCountList": {
              "BaselineDenomCount": [
                {
                  "BaselineDenomCountGroupId": "BG000",
                  "BaselineDenomCountValue": "15"
                },
                {
                  "BaselineDenomCountGroupId": "BG001",
                  "BaselineDenomCountValue": "14"
                },
                {
                  "BaselineDenomCountGroupId": "BG002",
                  "BaselineDenomCountValue": "5"
                },
                {
                  "BaselineDenomCountGroupId": "BG003",
                  "BaselineDenomCountValue": "16"
                },
                {
                  "BaselineDenomCountGroupId": "BG004",
                  "BaselineDenomCountValue": "50"
                }
              ]
            }
          }
        ]
      },
      "BaselineMeasureList": {
        "BaselineMeasure": [
          {
            "BaselineMeasureTitle": "Age, Continuous",
            "BaselineMeasureParamType": "Mean",
            "BaselineMeasureDispersionType": "Standard Deviation",
            "BaselineMeasureUnitOfMeasure": "Years",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "28.5",
                              "BaselineMeasurementSpread": "10.00"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "33.1",
                              "BaselineMeasurementSpread": "16.18"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "25.4",
                              "BaselineMeasurementSpread": "8.73"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "41.2",
                              "BaselineMeasurementSpread": "13.80"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG004",
                              "BaselineMeasurementValue": "33.6",
                              "BaselineMeasurementSpread": "14.00"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Sex: Female, Male",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Female",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "8"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "8"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG004",
                              "BaselineMeasurementValue": "25"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Male",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "3"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "8"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG004",
                              "BaselineMeasurementValue": "25"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Race/Ethnicity, Customized",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Asian",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG004",
                              "BaselineMeasurementValue": "1"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Black or African American",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG004",
                              "BaselineMeasurementValue": "3"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "White",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "13"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "11"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "4"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "15"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG004",
                              "BaselineMeasurementValue": "43"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Missing",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG004",
                              "BaselineMeasurementValue": "3"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "OutcomeMeasuresModule": {
      "OutcomeMeasureList": {
        "OutcomeMeasure": [
          {
            "OutcomeMeasureType": "Primary",
            "OutcomeMeasureTitle": "Objective Response Rate (ORR)",
            "OutcomeMeasureDescription": "ORR was calculated as the percentage of participants with a confirmed complete response (CR) or partial response (PR) relative to the total number of participants in the analysis population per response evaluation criteria in solid tumors (RECIST) version (v)1.1 as determined by the local investigators.",
            "OutcomeMeasurePopulationDescription": "Modified intent-to-treat (mITT) Population comprised of all participants who received NY-ESO-1 genetically engineered T cell infusion",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Number",
            "OutcomeMeasureUnitOfMeasure": "Percentage of Participants",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "12"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "13"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "5"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "15"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "50"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "30.8"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "20"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "26.7"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Duration of Overall Response",
            "OutcomeMeasureDescription": "Duration of overall response (DOR) is defined as the time from first documented evidence of confirmed CR or confirmed PR until first documented date of disease progression or death due to any cause or surgical resection or start of prohibited medications. Duration of overall response was evaluated per RECIST v1.1. Median and full range of DOR are presented.",
            "OutcomeMeasurePopulationDescription": "mITT Population. Only those participants with data available at the specified data points were analyzed.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "Full Range",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "6"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "4"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "1"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "4"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "31.0",
                              "OutcomeMeasurementLowerLimit": "13",
                              "OutcomeMeasurementUpperLimit": "72"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "8.6",
                              "OutcomeMeasurementLowerLimit": "8",
                              "OutcomeMeasurementUpperLimit": "13"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "32.1",
                              "OutcomeMeasurementLowerLimit": "NA",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "Full range is not applicable due to single participant, and the median value presented here is the actual DOR for this single participant."
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "16.4",
                              "OutcomeMeasurementLowerLimit": "14",
                              "OutcomeMeasurementUpperLimit": "94"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Progression Free Survival",
            "OutcomeMeasureDescription": "Progression free survival is defined as the interval between the date of first T cell infusion and the earliest documented evidence of disease progression or death due to any cause or surgical resection or start of prohibited medications. Progression free survival was evaluated per RECIST v1.1. Median and inter-quartile range (first quartile and third quartile) of progression free survival are presented.",
            "OutcomeMeasurePopulationDescription": "mITT Population",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "12"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "13"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "5"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "15"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "15.4",
                              "OutcomeMeasurementLowerLimit": "8.6",
                              "OutcomeMeasurementUpperLimit": "37.1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "13.1",
                              "OutcomeMeasurementLowerLimit": "8.3",
                              "OutcomeMeasurementUpperLimit": "13.9"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "8.6",
                              "OutcomeMeasurementLowerLimit": "8.3",
                              "OutcomeMeasurementUpperLimit": "12.1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "22.4",
                              "OutcomeMeasurementLowerLimit": "11.6",
                              "OutcomeMeasurementUpperLimit": "38.3"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Best Overall Response",
            "OutcomeMeasureDescription": "Best overall response is the best response recorded from the start of treatment (first T cell infusion) until disease progression/recurrence. Response categories from best to worst are confirmed CR, confirmed PR, stable disease (SD) and confirmed progressive disease (PD). Best overall response is a stable disease, if CR or PR are unconfirmed. Data for number of participants with CR, PR, SD and PD are presented.",
            "OutcomeMeasurePopulationDescription": "mITT Population",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "12"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "13"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "5"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "15"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeClassTitle": "Complete response",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "0"
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "OutcomeClassTitle": "Partial response",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "5"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "4"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "4"
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "OutcomeClassTitle": "Stable disease",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "5"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "7"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "3"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "10"
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "OutcomeClassTitle": "Progressive disease",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "1"
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "OutcomeClassTitle": "Not evaluable",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "0"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Overall Survival",
            "OutcomeMeasureDescription": "Overall survival is defined as the interval between the date of the first T-cell infusion and date of death from any cause. Median and inter-quartile range (first quartile and third quartile) of overall survival are presented.",
            "OutcomeMeasurePopulationDescription": "mITT Population",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "12"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "13"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "5"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "15"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "80.7",
                              "OutcomeMeasurementLowerLimit": "45.3",
                              "OutcomeMeasurementUpperLimit": "212.0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "43.1",
                              "OutcomeMeasurementLowerLimit": "19.4",
                              "OutcomeMeasurementUpperLimit": "85.3"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "86.4",
                              "OutcomeMeasurementLowerLimit": "68.1",
                              "OutcomeMeasurementUpperLimit": "104.6"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "105.3",
                              "OutcomeMeasurementLowerLimit": "50.3",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "<75% of participants experienced the event within the treatment arm. Hence, third quartile could not be derived."
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Number of Participants With Non-serious Adverse Events (Non-SAEs) and Serious Adverse Events (SAEs)",
            "OutcomeMeasureDescription": "An adverse event (AE) is any untoward medical occurrence in a clinical study participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. SAE is defined as any untoward medical occurrence that; results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect, other situations judged by physician, is associated with liver injury and impaired liver function. Number of participants who had non-SAEs and SAEs are presented.",
            "OutcomeMeasurePopulationDescription": "Intent-to-treat (ITT) Population comprised of all participants who were enrolled in the study.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "Up to 5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "15"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "14"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "5"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "16"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeClassTitle": "Non-SAE",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "15"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "13"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "5"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "15"
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "OutcomeClassTitle": "SAE",
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "9"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "7"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "4"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "6"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Number of Participants With Worst Post-Baseline Grade Results for Hematology Parameters",
            "OutcomeMeasureDescription": "Blood samples were collected for the analysis of hematology parameters. No data collected separately for this outcome measure as any abnormal value would be recorded as an adverse event.",
            "OutcomeMeasurePopulationDescription": "mITT Population",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Number of Participants With Worst Post-Baseline Grade Results for Clinical Chemistry Parameters",
            "OutcomeMeasureDescription": "Blood samples were collected for the analysis of clinical chemistry parameters. No data collected separately for this outcome measure as any abnormal value would be recorded as an adverse event.",
            "OutcomeMeasurePopulationDescription": "mITT Population",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Number of Participants With at Least One Confirmed Positive Post-Baseline Anti-infused (NY-ESO-1 Genetically Engineered T) Cell Antibody Result",
            "OutcomeMeasureDescription": "Serum samples were collected for the determination of anti-infused (NY-ESO-1 genetically engineered T) cell antibodies (ATA) using a validated electrochemiluminescent (ECL) immunoassay. The assay involved screening, confirmation and titration steps. If serum samples tested positive in the screening assay, they were considered 'potentially positive' and were further analyzed for the specificity using the confirmation assay. A participant was considered to have a confirmed positive ATA result if they have a positive screening assay result and a positive confirmation assay result.",
            "OutcomeMeasurePopulationDescription": "mITT Population. Only those participants with data available at the specified data points were analyzed.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "10"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "8"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "3"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "8"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "0"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Concentration of Cytokines in Cytokine Release Syndrome (CRS) by CRS Status: Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
            "OutcomeMeasureDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "OutcomeMeasurePopulationDescription": "mITT Population.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to Week 4",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Concentration of Cytokines in CRS by CRS Status: Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
            "OutcomeMeasureDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "OutcomeMeasurePopulationDescription": "mITT Population.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to Week 4",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Concentration of Cytokines in CRS by CRS Status: Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
            "OutcomeMeasureDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "OutcomeMeasurePopulationDescription": "mITT Population",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to Week 4",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Concentration of Cytokines in CRS by CRS Status: Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
            "OutcomeMeasureDescription": "CRS is a potentially life-threatening toxicity that is observed following administration of antibodies and adoptive T-cell therapies for cancer. Serum samples were collected to analyze the concentration of cytokines using the electrochemiluminescent tagged detection antibodies. The correlation between cytokines and cytokine release syndrome was considered between participants who had serious CRS vs no CRS or Non-serious CRS. There were only 4 participants across the whole study that had serious CRS and cytokine data was available for 3 of these participants. Due to the limited number of participants that had serious CRS no statistical correlations in cytokine levels and CRS could be performed. A listing of the levels of cytokines for the 3 participants with serious CRS is available/provided.",
            "OutcomeMeasurePopulationDescription": "mITT Population.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to Week 4",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Time to Maximum Persistence of NY-ESO-1 Genetically Engineered T Cells",
            "OutcomeMeasureDescription": "Time to maximum persistence is defined as date of maximum persistence for infusion visit minus date of first T cell infusion visit plus 1. Median and full range of time to maximum persistence are presented.",
            "OutcomeMeasurePopulationDescription": "mITT Population. Only those participants with data available at the specified data points were analyzed.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "Full Range",
            "OutcomeMeasureUnitOfMeasure": "Days",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "6"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "4"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "1"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "4"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "8.0",
                              "OutcomeMeasurementLowerLimit": "4",
                              "OutcomeMeasurementUpperLimit": "29"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "8.0",
                              "OutcomeMeasurementLowerLimit": "5",
                              "OutcomeMeasurementUpperLimit": "18"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "8.0",
                              "OutcomeMeasurementLowerLimit": "8",
                              "OutcomeMeasurementUpperLimit": "8"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "9",
                              "OutcomeMeasurementLowerLimit": "6",
                              "OutcomeMeasurementUpperLimit": "13"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Other Pre-specified",
            "OutcomeMeasureTitle": "Number of Participants With Dose-limiting Toxicities (DLTs)",
            "OutcomeMeasureDescription": "DLT was planned to be evaluated. An event was to be considered a DLT if it occurred within the first 21 days of treatment, and met one of the protocol defined DLT criteria. The results for this outcome measure will never be posted.",
            "OutcomeMeasurePopulationDescription": "mITT Population. This was an other pre-specified outcome measure. The results for this outcome measure will never be posted.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to Day 21 (from first dose)",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Other Pre-specified",
            "OutcomeMeasureTitle": "Number of Participants With Clinically Significant Abnormal Electrocardiogram, Echocardiogram and Multigated Acquisition Scan Findings",
            "OutcomeMeasureDescription": "Abnormal electrocardiogram, echocardiogram and multigated acquisition scan findings were planned to be evaluated. Clinical significance was based on the medical and scientific judgement of the investigator or qualified designee. The results for this outcome measure will never be posted.",
            "OutcomeMeasurePopulationDescription": "mITT Population. This was an other pre-specified outcome measure. The results for this outcome measure will never be posted.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Other Pre-specified",
            "OutcomeMeasureTitle": "Percentage of Participants With Confirmed CR",
            "OutcomeMeasureDescription": "Participants were planned to be evaluated for confirmed CR according to RECIST v1.1, after receiving a second dose of NY-ESO-1 genetically engineered T cell infusion. The results for this outcome measure will never be posted.",
            "OutcomeMeasurePopulationDescription": "mITT Population. This was an other pre-specified outcome measure. The results for this outcome measure will never be posted.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureTimeFrame": "Up to 4.5 years",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
                  "OutcomeGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
                  "OutcomeGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "0"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "0"
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "AdverseEventsModule": {
      "EventsFrequencyThreshold": "0",
      "EventsTimeFrame": "Serious adverse events (SAEs) and non-serious AEs were collected from the start of study treatment (Day 1) until maximum of 4.5 years",
      "EventsDescription": "SAEs and non-serious AEs were reported for the ITT Population which comprised of all participants who were enrolled in the study.",
      "EventGroupList": {
        "EventGroup": [
          {
            "EventGroupId": "EG000",
            "EventGroupTitle": "Cohort 1: High NY-ESO-1 Expression Treated With Regimen A",
            "EventGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, intravenously [IV] and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells.",
            "EventGroupDeathsNumAffected": "12",
            "EventGroupDeathsNumAtRisk": "15",
            "EventGroupSeriousNumAffected": "9",
            "EventGroupSeriousNumAtRisk": "15",
            "EventGroupOtherNumAffected": "15",
            "EventGroupOtherNumAtRisk": "15"
          },
          {
            "EventGroupId": "EG001",
            "EventGroupTitle": "Cohort 2: Low NY-ESO-1 Expression Treated With Regimen A",
            "EventGroupDescription": "Participants with low tumor expression of NY-ESO-1 underwent lymphodepletion with regimen A (lymphodepleting chemotherapeutic agents; cyclophosphamide plus fludarabine on Days -3 and -2, IV and only fludarabine on Days -5 and -4, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. Low tumor NY-ESO-1 expression was defined as >=1+ by IHC in >=1% cells but not to exceed 2+ or 3+ in >=50% cells.",
            "EventGroupDeathsNumAffected": "13",
            "EventGroupDeathsNumAtRisk": "14",
            "EventGroupSeriousNumAffected": "7",
            "EventGroupSeriousNumAtRisk": "14",
            "EventGroupOtherNumAffected": "13",
            "EventGroupOtherNumAtRisk": "14"
          },
          {
            "EventGroupId": "EG002",
            "EventGroupTitle": "Cohort 3: High NY-ESO-1 Expression Treated With Regimen B",
            "EventGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen B (lymphodepleting chemotherapeutic agent; cyclophosphamide only on Days -3 and -2, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells.",
            "EventGroupDeathsNumAffected": "4",
            "EventGroupDeathsNumAtRisk": "5",
            "EventGroupSeriousNumAffected": "4",
            "EventGroupSeriousNumAtRisk": "5",
            "EventGroupOtherNumAffected": "5",
            "EventGroupOtherNumAtRisk": "5"
          },
          {
            "EventGroupId": "EG003",
            "EventGroupTitle": "Cohort 4: High NY-ESO-1 Expression Treated With Regimen C",
            "EventGroupDescription": "Participants with high tumor expression of NY-ESO-1 underwent lymphodepletion with regimen C (lymphodepleting chemotherapeutic agents; reduced dose of cyclophosphamide plus fludarabine on Days -7 to -5, IV). Participants received one infusion of NY-ESO-1 genetically engineered T cells on Day 0. High tumor NY-ESO-1 expression was defined as 2+ or 3+ by immunohistochemistry (IHC) in >=50% cells.",
            "EventGroupDeathsNumAffected": "8",
            "EventGroupDeathsNumAtRisk": "16",
            "EventGroupSeriousNumAffected": "6",
            "EventGroupSeriousNumAtRisk": "16",
            "EventGroupOtherNumAffected": "15",
            "EventGroupOtherNumAtRisk": "16"
          }
        ]
      },
      "SeriousEventList": {
        "SeriousEvent": [
          {
            "SeriousEventTerm": "Dyspnoea",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pneumothorax",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Hypoxia",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pleural effusion",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Respiratory failure",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Cough",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Haemoptysis",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pleuritic pain",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pneumonitis",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pulmonary haemorrhage",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pyrexia",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "4",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "3",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Chills",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Chest pain",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Non-cardiac chest pain",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Febrile neutropenia",
            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Bone marrow failure",
            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Anaemia",
            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Neutropenia",
            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Embolism",
            "SeriousEventOrganSystem": "Vascular disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Hypotension",
            "SeriousEventOrganSystem": "Vascular disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "3",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Diarrhoea",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Abdominal pain",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Anal ulcer",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Enterocolitis",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Nausea",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Proctalgia",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Vomiting",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Cytokine release syndrome",
            "SeriousEventOrganSystem": "Immune system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "3",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Bacteraemia",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Cytomegalovirus infection",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Device related infection",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Lung infection",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Myocardial infarction",
            "SeriousEventOrganSystem": "Cardiac disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pericardial effusion",
            "SeriousEventOrganSystem": "Cardiac disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Supraventricular tachycardia",
            "SeriousEventOrganSystem": "Cardiac disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Neutrophil count decreased",
            "SeriousEventOrganSystem": "Investigations",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Platelet count decreased",
            "SeriousEventOrganSystem": "Investigations",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "White blood cell count decreased",
            "SeriousEventOrganSystem": "Investigations",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Guillain-Barre syndrome",
            "SeriousEventOrganSystem": "Nervous system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Spinal cord compression",
            "SeriousEventOrganSystem": "Nervous system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Dehydration",
            "SeriousEventOrganSystem": "Metabolism and nutrition disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Hypokalaemia",
            "SeriousEventOrganSystem": "Metabolism and nutrition disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Leukaemia",
            "SeriousEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Tumour haemorrhage",
            "SeriousEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Tumour pain",
            "SeriousEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Acute kidney injury",
            "SeriousEventOrganSystem": "Renal and urinary disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Rash maculo-papular",
            "SeriousEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Cholecystitis acute",
            "SeriousEventOrganSystem": "Hepatobiliary disorders",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Vascular access complication",
            "SeriousEventOrganSystem": "Injury, poisoning and procedural complications",
            "SeriousEventSourceVocabulary": "MedDRA 22.0",
            "SeriousEventAssessmentType": "Systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "15"
                },
                {
                  "SeriousEventStatsGroupId": "EG001",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "14"
                },
                {
                  "SeriousEventStatsGroupId": "EG002",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "5"
                },
                {
                  "SeriousEventStatsGroupId": "EG003",
                  "SeriousEventStatsNumAffected": "0",
                  "SeriousEventStatsNumAtRisk": "16"
                }
              ]
            }
          }
        ]
      },
      "OtherEventList": {
        "OtherEvent": [
          {
            "OtherEventTerm": "Fatigue",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "12",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "14",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pyrexia",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "12",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oedema peripheral",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Chills",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Non-cardiac chest pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Chest pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Asthenia",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Injection site reaction",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Chest discomfort",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Influenza like illness",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Malaise",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Mucosal inflammation",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Multiple organ dysfunction syndrome",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Peripheral swelling",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Tenderness",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Catheter site bruise",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Catheter site irritation",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Catheter site pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Catheter site vesicles",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Face oedema",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Facial pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Gait disturbance",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Generalised oedema",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Infusion site extravasation",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Localised oedema",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oedema",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "White blood cell count decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "12",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "12",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Lymphocyte count decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "13",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Neutrophil count decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "11",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Platelet count decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "12",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Alanine aminotransferase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood creatinine increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Activated partial thromboplastin time prolonged",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Aspartate aminotransferase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood alkaline phosphatase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Weight decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Lipase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Amylase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood bilirubin increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood creatine phosphokinase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Breath sounds abnormal",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "C-reactive protein increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ejection fraction decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Haemoglobin decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "International normalised ratio increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Serum ferritin increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Urine output decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood pressure diastolic increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cytomegalovirus test positive",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Electrocardiogram QT prolonged",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Electrocardiogram abnormal",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Epstein-Barr virus antibody positive",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Transaminases increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "White blood cells urine positive",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Anaemia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "14",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "13",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Febrile neutropenia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Neutropenia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Thrombocytopenia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Leukopenia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Leukocytosis",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Nausea",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "13",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "13",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Diarrhoea",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vomiting",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Constipation",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Abdominal pain",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dyspepsia",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Abdominal distension",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dysphagia",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Proctalgia",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Abdominal pain upper",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dry mouth",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Gastritis",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Gastrooesophageal reflux disease",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Stomatitis",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Lip dry",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oral dysaesthesia",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oral mucosal erythema",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ascites",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Change of bowel habit",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Gastrointestinal pain",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Haemorrhoidal haemorrhage",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ileus",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Mouth ulceration",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oral disorder",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oral pain",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Scalloped tongue",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Small intestinal obstruction",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypophosphataemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyponatraemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "11",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Decreased appetite",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypoalbuminaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypokalaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypocalcaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypomagnesaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dehydration",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperglycaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperkalaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypermagnesaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Appetite disorder",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperchloraemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperphosphataemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperuricaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypoglycaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Lactic acidosis",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Metabolic acidosis",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vitamin D deficiency",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Musculoskeletal chest pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pain in extremity",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Back pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Myalgia",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Arthralgia",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Musculoskeletal pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Neck pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Bone pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Flank pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Muscular weakness",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Muscle spasms",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pain in jaw",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Joint range of motion decreased",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Limb discomfort",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Mobility decreased",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Musculoskeletal discomfort",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Trismus",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dyspnoea",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cough",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypoxia",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Nasal congestion",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pleural effusion",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Tachypnoea",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oropharyngeal pain",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pleuritic pain",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dysphonia",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Productive cough",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rhinitis allergic",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rhinorrhoea",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Throat irritation",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Atelectasis",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dyspnoea exertional",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Epistaxis",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Haemoptysis",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pulmonary embolism",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Wheezing",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Aspiration",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hiccups",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypopnoea",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Laryngeal haemorrhage",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Nasal dryness",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pneumonitis",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pneumothorax",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pulmonary haemorrhage",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pulmonary oedema",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Sinus tachycardia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Tachycardia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pericardial effusion",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Sinus bradycardia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Atrial fibrillation",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Palpitations",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Right ventricular dysfunction",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Angina pectoris",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Aortic valve disease",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Arrhythmia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Atrial flutter",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Bradycardia",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cardiac tamponade",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cardiomyopathy",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Mitral valve disease",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pulmonary valve disease",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Tricuspid valve disease",
            "OtherEventOrganSystem": "Cardiac disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pruritus",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rash maculo-papular",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Alopecia",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rash",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dry skin",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Erythema",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Skin hyperpigmentation",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Acne",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dermatitis acneiform",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dermatitis exfoliative generalised",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperhidrosis",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Night sweats",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pain of skin",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Skin exfoliation",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Angioedema",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cold sweat",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dermatitis",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ecchymosis",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Nail disorder",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Onychomadesis",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Petechiae",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Purpura",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rash erythematous",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rash macular",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rash papular",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Skin discolouration",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Skin ulcer",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Subcutaneous emphysema",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dizziness",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Headache",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Paraesthesia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Peripheral sensory neuropathy",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dysgeusia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Neuralgia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Disturbance in attention",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Lethargy",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Migraine",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Peripheral motor neuropathy",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Presyncope",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dysarthria",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Memory impairment",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Neuropathy peripheral",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Neurotoxicity",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Peripheral sensorimotor neuropathy",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Phantom limb syndrome",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Somnolence",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Tremor",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Anxiety",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Insomnia",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Depression",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Confusional state",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Agitation",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Mental status changes",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Paranoia",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Restlessness",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Sleep disorder",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Social avoidant behaviour",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Suicidal ideation",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypotension",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypertension",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hot flush",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Embolism",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Flushing",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pallor",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Deep vein thrombosis",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vena cava thrombosis",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Upper respiratory tract infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pneumonia",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Urinary tract infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Device related infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Folliculitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Abscess",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Acute sinusitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Beta haemolytic streptococcal infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Bronchitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Clostridium difficile colitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cytomegalovirus infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Diverticulitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Eye infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Groin infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Herpes zoster",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Lung infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Nasopharyngitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oral candidiasis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Paronychia",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pseudomonas infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rhinitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rhinovirus infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Sinusitis",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Staphylococcal infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Streptococcal bacteraemia",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vaginal infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Viral infection",
            "OtherEventOrganSystem": "Infections and infestations",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cytokine release syndrome",
            "OtherEventOrganSystem": "Immune system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "4",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypersensitivity",
            "OtherEventOrganSystem": "Immune system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Drug hypersensitivity",
            "OtherEventOrganSystem": "Immune system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Seasonal allergy",
            "OtherEventOrganSystem": "Immune system disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Proteinuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Haematuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "3",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Acute kidney injury",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Urinary tract pain",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dysuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Haemoglobinuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pollakiuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Anuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Chromaturia",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Chronic kidney disease",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Fanconi syndrome acquired",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Glycosuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Micturition urgency",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oliguria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Renal tubular acidosis",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Urinary retention",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Contusion",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Fall",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Incision site pain",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Transfusion reaction",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Infusion related reaction",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Limb injury",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Procedural pain",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Skin abrasion",
            "OtherEventOrganSystem": "Injury, poisoning and procedural complications",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vision blurred",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dry eye",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Eye pruritus",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Eyelid ptosis",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Periorbital oedema",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Photophobia",
            "OtherEventOrganSystem": "Eye disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Tumour pain",
            "OtherEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Infected neoplasm",
            "OtherEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Neoplasm skin",
            "OtherEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Premature menopause",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Genital rash",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Menorrhagia",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Menstruation irregular",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oedema genital",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pelvic pain",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pruritus genital",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vaginal discharge",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vaginal haemorrhage",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vulvovaginal dryness",
            "OtherEventOrganSystem": "Reproductive system and breast disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ear pain",
            "OtherEventOrganSystem": "Ear and labyrinth disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Eustachian tube dysfunction",
            "OtherEventOrganSystem": "Ear and labyrinth disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "External ear inflammation",
            "OtherEventOrganSystem": "Ear and labyrinth disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperthyroidism",
            "OtherEventOrganSystem": "Endocrine disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypothyroidism",
            "OtherEventOrganSystem": "Endocrine disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "1",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperbilirubinaemia",
            "OtherEventOrganSystem": "Hepatobiliary disorders",
            "OtherEventSourceVocabulary": "MedDRA 22.0",
            "OtherEventAssessmentType": "Systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "15"
                },
                {
                  "OtherEventStatsGroupId": "EG001",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "14"
                },
                {
                  "OtherEventStatsGroupId": "EG002",
                  "OtherEventStatsNumAffected": "0",
                  "OtherEventStatsNumAtRisk": "5"
                },
                {
                  "OtherEventStatsGroupId": "EG003",
                  "OtherEventStatsNumAffected": "2",
                  "OtherEventStatsNumAtRisk": "16"
                }
              ]
            }
          }
        ]
      }
    },
    "MoreInfoModule": {
      "CertainAgreement": {
        "AgreementPISponsorEmployee": "No",
        "AgreementRestrictionType": "OTHER",
        "AgreementRestrictiveAgreement": "Yes",
        "AgreementOtherDetails": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."
      },
      "PointOfContact": {
        "PointOfContactTitle": "GSK Response Center",
        "PointOfContactOrganization": "GlaxoSmithKline",
        "PointOfContactEMail": "GSKClinicalSupportHD@gsk.com",
        "PointOfContactPhone": "866-435-7343"
      }
    }
  },
  "DocumentSection": {
    "LargeDocumentModule": {
      "LargeDocList": {
        "LargeDoc": [
          {
            "LargeDocTypeAbbrev": "Prot",
            "LargeDocHasProtocol": "Yes",
            "LargeDocHasSAP": "No",
            "LargeDocHasICF": "No",
            "LargeDocLabel": "Study Protocol",
            "LargeDocDate": "October 17, 2018",
            "LargeDocUploadDate": "04/23/2020 10:32",
            "LargeDocFilename": "Prot_000.pdf"
          },
          {
            "LargeDocTypeAbbrev": "SAP",
            "LargeDocHasProtocol": "No",
            "LargeDocHasSAP": "Yes",
            "LargeDocHasICF": "No",
            "LargeDocLabel": "Statistical Analysis Plan",
            "LargeDocDate": "November 7, 2019",
            "LargeDocUploadDate": "04/23/2020 10:36",
            "LargeDocFilename": "SAP_001.pdf"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022",
      "RemovedCountryList": {
        "RemovedCountry": [
          "Canada",
          "France",
          "United Kingdom"
        ]
      }
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000012509",
            "ConditionMeshTerm": "Sarcoma"
          },
          {
            "ConditionMeshId": "D000013584",
            "ConditionMeshTerm": "Sarcoma, Synovial"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000018204",
            "ConditionAncestorTerm": "Neoplasms, Connective and Soft Tissue"
          },
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000009372",
            "ConditionAncestorTerm": "Neoplasms, Connective Tissue"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14479",
            "ConditionBrowseLeafName": "Sarcoma",
            "ConditionBrowseLeafAsFound": "Sarcoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M15513",
            "ConditionBrowseLeafName": "Sarcoma, Synovial",
            "ConditionBrowseLeafAsFound": "Synovial Sarcoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M19502",
            "ConditionBrowseLeafName": "Neoplasms, Connective and Soft Tissue",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11469",
            "ConditionBrowseLeafName": "Neoplasms, Connective Tissue",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T5284",
            "ConditionBrowseLeafName": "Soft Tissue Sarcoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T5553",
            "ConditionBrowseLeafName": "Synovial Sarcoma",
            "ConditionBrowseLeafAsFound": "Synovial Sarcoma",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000003520",
            "InterventionMeshTerm": "Cyclophosphamide"
          },
          {
            "InterventionMeshId": "C000024352",
            "InterventionMeshTerm": "Fludarabine"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000007166",
            "InterventionAncestorTerm": "Immunosuppressive Agents"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000018501",
            "InterventionAncestorTerm": "Antirheumatic Agents"
          },
          {
            "InterventionAncestorId": "D000018906",
            "InterventionAncestorTerm": "Antineoplastic Agents, Alkylating"
          },
          {
            "InterventionAncestorId": "D000000477",
            "InterventionAncestorTerm": "Alkylating Agents"
          },
          {
            "InterventionAncestorId": "D000045504",
            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
          },
          {
            "InterventionAncestorId": "D000000970",
            "InterventionAncestorTerm": "Antineoplastic Agents"
          },
          {
            "InterventionAncestorId": "D000019653",
            "InterventionAncestorTerm": "Myeloablative Agonists"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M5879",
            "InterventionBrowseLeafName": "Cyclophosphamide",
            "InterventionBrowseLeafAsFound": "Months",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M283219",
            "InterventionBrowseLeafName": "Fludarabine",
            "InterventionBrowseLeafAsFound": "Medical",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M225481",
            "InterventionBrowseLeafName": "Fludarabine phosphate",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9364",
            "InterventionBrowseLeafName": "Immunosuppressive Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M19757",
            "InterventionBrowseLeafName": "Antirheumatic Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M20095",
            "InterventionBrowseLeafName": "Antineoplastic Agents, Alkylating",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M2972",
            "InterventionBrowseLeafName": "Alkylating Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "ANeo",
            "InterventionBrowseBranchName": "Antineoplastic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "ARhu",
            "InterventionBrowseBranchName": "Antirheumatic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}